Biallelic variants in PCDHGC4 cause a novel neurodevelopmental syndrome with progressive microcephaly, seizures, and joint anomalies.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
11 2021
Historique:
received: 19 03 2021
accepted: 15 06 2021
revised: 14 06 2021
pubmed: 11 7 2021
medline: 12 11 2021
entrez: 10 7 2021
Statut: ppublish

Résumé

We aimed to define a novel autosomal recessive neurodevelopmental disorder, characterize its clinical features, and identify the underlying genetic cause for this condition. We performed a detailed clinical characterization of 19 individuals from nine unrelated, consanguineous families with a neurodevelopmental disorder. We used genome/exome sequencing approaches, linkage and cosegregation analyses to identify disease-causing variants, and we performed three-dimensional molecular in silico analysis to predict causality of variants where applicable. In all affected individuals who presented with a neurodevelopmental syndrome with progressive microcephaly, seizures, and intellectual disability we identified biallelic disease-causing variants in Protocadherin-gamma-C4 (PCDHGC4). Five variants were predicted to induce premature protein truncation leading to a loss of PCDHGC4 function. The three detected missense variants were located in extracellular cadherin (EC) domains EC5 and EC6 of PCDHGC4, and in silico analysis of the affected residues showed that two of these substitutions were predicted to influence the Ca We show that biallelic variants in PCDHGC4 are causing a novel autosomal recessive neurodevelopmental disorder and link PCDHGC4 as a member of the clustered PCDH family to a Mendelian disorder in humans.

Identifiants

pubmed: 34244665
doi: 10.1038/s41436-021-01260-4
pii: S1098-3600(21)05184-4
pmc: PMC8553613
doi:

Substances chimiques

Cadherin Related Proteins 0
Cadherins 0
Gamma-protocadherins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2138-2149

Subventions

Organisme : Medical Research Council
ID : G0601943
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009203/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/M009203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S005021/1
Pays : United Kingdom

Investigateurs

J C Ambrose (JC)
P Arumugam (P)
M Bleda (M)
F Boardman-Pretty (F)
C R Boustred (CR)
H Brittain (H)
M J Caulfield (MJ)
G C Chan (GC)
T Fowler (T)
A Giess (A)
A Hamblin (A)
S Henderson (S)
T J P Hubbard (TJP)
R Jackson (R)
L J Jones (LJ)
D Kasperaviciute (D)
M Kayikci (M)
A Kousathanas (A)
L Lahnstein (L)
S E A Leigh (SEA)
I U Leong (IU)
F J Lopez (FJ)
F Maleady-Crowe (F)
L Moutsianas (L)
M Mueller (M)
N Murugaesu (N)
A C Need (AC)
P O'Donovan (P)
C A Odhams (CA)
C Patch (C)
D Perez-Gil (D)
M B Pereira (MB)
J Pullinger (J)
T Rahim (T)
A Rendon (A)
T Rogers (T)
K Savage (K)
K Sawant (K)
R H Scott (RH)
A Siddiq (A)
A Sieghart (A)
S C Smith (SC)
A Sosinsky (A)
A Stuckey (A)
M Tanguy (M)
E R A Thomas (ERA)
S R Thompson (SR)
A Tucci (A)
E Walsh (E)
M J Welland (MJ)
E Williams (E)
K Witkowska (K)
S M Wood (SM)

Informations de copyright

© 2021. The Author(s).

Références

Sano K, et al. Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J. 1993;12:2249–2256.
doi: 10.1002/j.1460-2075.1993.tb05878.x
Rubinstein R, et al. Molecular logic of neuronal self-recognition through protocadherin domain interactions. Cell. 2015;163:629–642. https://doi.org/10.1016/j.cell.2015.09.026 .
doi: 10.1016/j.cell.2015.09.026 pubmed: 26478182 pmcid: 4624033
Hulpiau P, van Roy F. Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol. 2009;41:349–369. https://doi.org/10.1016/j.biocel.2008.09.027 .
doi: 10.1016/j.biocel.2008.09.027 pubmed: 18848899
Wu Q, Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell. 1999;97:779–790. https://doi.org/10.1016/s0092-8674(00)80789-8 .
doi: 10.1016/s0092-8674(00)80789-8 pubmed: 10380929
Sugino H, et al. Genomic organization of the family of CNR cadherin genes in mice and humans. Genomics. 2000;63:75–87. https://doi.org/10.1006/geno.1999.6066 .
doi: 10.1006/geno.1999.6066 pubmed: 10662547
Wu Q, et al. Comparative DNA sequence analysis of mouse and human protocadherin gene clusters Genome Res. 2001;11:389–404. https://doi.org/10.1101/gr.167301 .
doi: 10.1101/gr.167301
Wu Q, Maniatis T. Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. Proc Natl Acad Sci USA. 2000;97:3124–3129. https://doi.org/10.1073/pnas.060027397 .
doi: 10.1073/pnas.060027397 pubmed: 10716726 pmcid: 16203
Wang X, Weiner JA, Levi S, Craig AM, Bradley A, Sanes JR. Gamma protocadherins are required for survival of spinal interneurons. Neuron. 2002;36:843–854. https://doi.org/10.1016/s0896-6273(02)01090-5 .
doi: 10.1016/s0896-6273(02)01090-5 pubmed: 12467588
Lefebvre JL, Kostadinov D, Chen WV, Maniatis T, Sanes JR. Protocadherins mediate dendritic self-avoidance in the mammalian nervous system. Nature. 2012;488:517–521. https://doi.org/10.1038/nature11305 .
doi: 10.1038/nature11305 pubmed: 22842903 pmcid: 3427422
Chen WV, et al. Pcdhαc2 is required for axonal tiling and assembly of serotonergic circuitries in mice. Science. 2017;356:406–411. https://doi.org/10.1126/science.aal3231 .
doi: 10.1126/science.aal3231 pubmed: 28450636 pmcid: 5529183
Mountoufaris G, et al. Multicluster Pcdh diversity is required for mouse olfactory neural circuit assembly. Science. 2017;356:411–414. https://doi.org/10.1126/science.aai8801 .
doi: 10.1126/science.aai8801 pubmed: 28450637 pmcid: 5529182
Murata Y, Hamada S, Morishita H, Mutoh T, Yagi T. Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. J Biol Chem. 2004;279:49508–49516. https://doi.org/10.1074/jbc.M408771200 .
doi: 10.1074/jbc.M408771200 pubmed: 15347688
Fernández-Monreal M, Kang S, Phillips GR. Gamma-protocadherin homophilic interaction and intracellular trafficking is controlled by the cytoplasmic domain in neurons. Mol Cell Neurosci. 2009;40:344–353. https://doi.org/10.1016/j.mcn.2008.12.002 .
doi: 10.1016/j.mcn.2008.12.002 pubmed: 19136062
Schreiner D, Weiner JA. Combinatorial homophilic interaction between gamma-protocadherin multimers greatly expands the molecular diversity of cell adhesion. Proc Natl Acad Sci USA. 2010;107:14893–14898. https://doi.org/10.1073/pnas.1004526107 .
doi: 10.1073/pnas.1004526107 pubmed: 20679223 pmcid: 2930437
Thu CA, et al. Single-cell identity generated by combinatorial homophilic interactions between α, β, and γ protocadherins. Cell. 2014;158:1045–1059. https://doi.org/10.1016/j.cell.2014.07.012 .
doi: 10.1016/j.cell.2014.07.012 pubmed: 25171406 pmcid: 4183217
Hasegawa S, et al. The protocadherin-alpha family is involved in axonal coalescence of olfactory sensory neurons into glomeruli of the olfactory bulb in mouse. Mol Cell Neurosci. 2008;38:66–79. https://doi.org/10.1016/j.mcn.2008.01.016 .
doi: 10.1016/j.mcn.2008.01.016 pubmed: 18353676
Garrett AM, Schreiner D, Lobas MA, Weiner JA. γ-protocadherins control cortical dendrite arborization by regulating the activity of a FAK/PKC/MARCKS signaling pathway. Neuron. 2012;74:269–276. https://doi.org/10.1016/j.neuron.2012.01.028 .
doi: 10.1016/j.neuron.2012.01.028 pubmed: 22542181 pmcid: 3582349
Molumby MJ, Keeler AB, Weiner JA. Homophilic protocadherin cell-cell interactions promote dendrite complexity. Cell Rep. 2016;15:1037–1050. https://doi.org/10.1016/j.celrep.2016.03.093 .
doi: 10.1016/j.celrep.2016.03.093 pubmed: 27117416 pmcid: 4856576
Katori S, et al. Protocadherin-alpha family is required for serotonergic projections to appropriately innervate target brain areas. J Neurosci. 2009;29:9137–9147. https://doi.org/10.1523/JNEUROSCI.5478-08.2009 .
doi: 10.1523/JNEUROSCI.5478-08.2009 pubmed: 19625505 pmcid: 6665563
Weiner JA, Wang X, Tapia JC, Sanes JR. Gamma protocadherins are required for synaptic development in the spinal cord. Proc Natl Acad Sci USA. 2005;102:8–14. https://doi.org/10.1073/pnas.0407931101 .
doi: 10.1073/pnas.0407931101 pubmed: 15574493
Prasad T, Wang X, Gray PA, Weiner JA. A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster. Dev Camb Engl. 2008;135:4153–4164. https://doi.org/10.1242/dev.026807 .
doi: 10.1242/dev.026807
Chen WV, et al. Functional significance of isoform diversification in the protocadherin gamma gene cluster. Neuron. 2012;75:402–409. https://doi.org/10.1016/j.neuron.2012.06.039 .
doi: 10.1016/j.neuron.2012.06.039 pubmed: 22884324 pmcid: 3426296
Garrett AM, et al. CRISPR/Cas9 interrogation of the mouse Pcdhg gene cluster reveals a crucial isoform-specific role for Pcdhgc4. PLoS Genet. 2019;15:e1008554. https://doi.org/10.1371/journal.pgen.1008554 .
doi: 10.1371/journal.pgen.1008554 pubmed: 31877124 pmcid: 6957209
Guemez-Gamboa A, et al. Loss of protocadherin-12 leads to diencephalic-mesencephalic junction dysplasia syndrome. Ann Neurol. 2018;84:638–647. https://doi.org/10.1002/ana.25327 .
doi: 10.1002/ana.25327 pubmed: 30178464 pmcid: 6510237
Ahmed ZM, et al. PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23. Hum Mol Genet. 2003;12:3215–3223. https://doi.org/10.1093/hmg/ddg358 .
doi: 10.1093/hmg/ddg358 pubmed: 14570705
Dibbens LM, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet. 2008;40:776–781. https://doi.org/10.1038/ng.149 .
doi: 10.1038/ng.149 pubmed: 18469813 pmcid: 2756413
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–930. https://doi.org/10.1002/humu.22844 .
doi: 10.1002/humu.22844 pubmed: 26220891 pmcid: 4833888
Cailliez F, Lavery R. Cadherin mechanics and complexation: the importance of calcium binding. Biophys J. 2005;89:3895–3903. https://doi.org/10.1529/biophysj.105.067322 .
doi: 10.1529/biophysj.105.067322 pubmed: 16183887 pmcid: 1366956
Sotomayor M, Schulten K. The allosteric role of the Ca
doi: 10.1529/biophysj.107.125591 pubmed: 18326636 pmcid: 2397358
Depienne C, LeGuern E. PCDH19-related infantile epileptic encephalopathy: an unusual X-linked inheritance disorder. Hum Mutat. 2012;33:627–634. https://doi.org/10.1002/humu.22029 .
doi: 10.1002/humu.22029 pubmed: 22267240
Goodman KM, et al. γ-Protocadherin structural diversity and functional implications. eLife. 2016;5:e20930. https://doi.org/10.7554/eLife.20930 .
Dudek FE, Shao L-R. Loss of GABAergic interneurons in seizure-induced epileptogenesis. Epilepsy Curr. 2003;3:159–161. https://doi.org/10.1046/j.1535-7597.2003.03503.x .
doi: 10.1046/j.1535-7597.2003.03503.x pubmed: 15902313 pmcid: 557954
Southwell DG, et al. Intrinsically determined cell death of developing cortical interneurons. Nature. 2012;491:109–113. https://doi.org/10.1038/nature11523 .
doi: 10.1038/nature11523 pubmed: 23041929 pmcid: 3726009
Denaxa M, et al. Modulation of apoptosis controls inhibitory interneuron number in the cortex. Cell Rep. 2018;22:1710–1721. https://doi.org/10.1016/j.celrep.2018.01.064 .
doi: 10.1016/j.celrep.2018.01.064 pubmed: 29444425 pmcid: 6230259
Wong FK, et al. Pyramidal cell regulation of interneuron survival sculpts cortical networks. Nature. 2018;557:668–673. https://doi.org/10.1038/s41586-018-0139-6 .
doi: 10.1038/s41586-018-0139-6 pubmed: 29849154 pmcid: 6207348
Mancia Leon WR, et al. Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. eLife. 2020;9:e55374. https://doi.org/10.7554/eLife.55374 .
Mincheva-Tasheva S, Nieto Guil AF, Homan CC, Gecz J, Thomas PQ. Disrupted excitatory synaptic contacts and altered neuronal network activity underpins the neurological phenotype in PCDH19-clustering epilepsy (PCDH19-CE). Mol Neurobiol. 2021;58:2005–2018. https://doi.org/10.1007/s12035-020-02242-4 .
Dallosso AR, et al. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene. 2012;31:4409–4419. https://doi.org/10.1038/onc.2011.609 .
doi: 10.1038/onc.2011.609 pubmed: 22249255 pmcid: 3647107
Strong E, et al. Symmetrical dose-dependent DNA-methylation profiles in children with deletion or duplication of 7q11.23. Am J Hum Genet. 2015;97:216–227. https://doi.org/10.1016/j.ajhg.2015.05.019 .
doi: 10.1016/j.ajhg.2015.05.019 pubmed: 26166478 pmcid: 4573259
El Hajj N, et al. Epigenetic dysregulation in the developing Down syndrome cortex. Epigenetics. 2016;11:563–578. https://doi.org/10.1080/15592294.2016.1192736 .
doi: 10.1080/15592294.2016.1192736 pubmed: 27245352 pmcid: 4990229

Auteurs

Maria Iqbal (M)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany.
Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.

Reza Maroofian (R)

Department of Neuromuscular Disorders, UCL Institute of Neurology, London, UK.

Büşranur Çavdarlı (B)

Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Turkey.

Florence Riccardi (F)

Aix Marseille Univ, INSERM, MMG, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Hôpital La Timone Enfants, Département de Génétique Médicale, Marseille, France.

Michael Field (M)

Genetics of Learning Disability Service, Hunter Genetics, Waratah, NSW, Australia.

Siddharth Banka (S)

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Dalal K Bubshait (DK)

Department of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Yun Li (Y)

Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.

Jozef Hertecant (J)

Paediatric Genetic and Metabolic Service, Tawam Hospital, Al Ain, United Arab Emirates.

Shahid Mahmood Baig (SM)

Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.
Pakistan Science Foundation (PSF), Islamabad, Pakistan.

David Dyment (D)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.

Stephanie Efthymiou (S)

Department of Neuromuscular Disorders, UCL Institute of Neurology, London, UK.

Uzma Abdullah (U)

University Institute of Biochemistry and Biotechnology (UIBB), PMAS-Arid Agriculture University, Rawalpindi, Pakistan.

Ehtisham Ul Haq Makhdoom (EUH)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany.
Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.
Neurochemicalbiology and Genetics Laboratory (NGL), Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, Pakistan.

Zafar Ali (Z)

Centre for Biotechnology and Microbiology, University of Swat, Swat, Pakistan.

Tobias Scherf de Almeida (T)

Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.

Florence Molinari (F)

Aix Marseille Univ, INSERM, MMG, Marseille, France.

Cécile Mignon-Ravix (C)

Aix Marseille Univ, INSERM, MMG, Marseille, France.

Brigitte Chabrol (B)

Assistance Publique-Hôpitaux de Marseille, APHM, Hôpital Timone Enfants, Service de Neurologie Pédiatrique, Marseille, France.

Jayne Antony (J)

T.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Sydney, Australia.

Lesley Ades (L)

Specialty of Child and Adolescent Health and Discipline of Genomic Medicine, The Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, Australia.
Department of Clinical Genetics, The Children's Hospital at Westmead, Sydney, Australia.

Alistair T Pagnamenta (AT)

National Institute for Health Research Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Adam Jackson (A)

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Sofia Douzgou (S)

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Christian Beetz (C)

CENTOGENE GmbH, Rostock, Germany.

Vasiliki Karageorgou (V)

CENTOGENE GmbH, Rostock, Germany.

Barbara Vona (B)

Department of Otolaryngology, Head and Neck Surgery, Tübingen Hearing Research Centre (THRC), Eberhard Karls University Tübingen, Tübingen, Germany.

Aboulfazl Rad (A)

Department of Otolaryngology, Head and Neck Surgery, Tübingen Hearing Research Centre (THRC), Eberhard Karls University Tübingen, Tübingen, Germany.

Jamshaid Mahmood Baig (JM)

Department of Bioinformatics & Biotechnology, Faculty of Basic and Applied Sciences, International Islamic University, Islamabad, Pakistan.

Tipu Sultan (T)

Department of Pediatric Neurology, Children's Hospital and Institute of Child Health, Lahore, Pakistan.

Javeria Raza Alvi (JR)

Department of Pediatric Neurology, Children's Hospital and Institute of Child Health, Lahore, Pakistan.

Shazia Maqbool (S)

Development and Behavioural Pediatrics Department, Institute of Child Health and The Children Hospital, Lahore, Pakistan.

Fatima Rahman (F)

Development and Behavioural Pediatrics Department, Institute of Child Health and The Children Hospital, Lahore, Pakistan.

Mehran Beiraghi Toosi (MB)

Pediatric Neurology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Farah Ashrafzadeh (F)

Pediatric Neurology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Shima Imannezhad (S)

Pediatric Neurology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Ehsan Ghayoor Karimiani (EG)

Molecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London, UK.
Innovative Medical Research Center, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Yasra Sarwar (Y)

Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.

Sheraz Khan (S)

Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.

Muhammad Jameel (M)

Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.

Angelika A Noegel (AA)

Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.

Birgit Budde (B)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.

Janine Altmüller (J)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.

Susanne Motameny (S)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.

Wolfgang Höhne (W)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.

Henry Houlden (H)

Department of Neuromuscular Disorders, UCL Institute of Neurology, London, UK.

Peter Nürnberg (P)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.

Bernd Wollnik (B)

Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany.

Laurent Villard (L)

Aix Marseille Univ, INSERM, MMG, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Hôpital La Timone Enfants, Département de Génétique Médicale, Marseille, France.

Fowzan Sami Alkuraya (FS)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Matthew Osmond (M)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.

Muhammad Sajid Hussain (MS)

Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany. mhussain@uni-koeln.de.
Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany. mhussain@uni-koeln.de.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany. mhussain@uni-koeln.de.

Gökhan Yigit (G)

Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany. goekhan.yigit@med.uni-goettingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH